Dr Bradstreet has full Autism recoveries with our GcMAF. See "Participants experiences"
It is our immune system that prevents and destroys disease
A macrophage (purple) eats cancer cellsThe first research was done in 1990 by Dr Yamamoto in Philadelphia and since then over 46 research papers have been published by over 100 scientists indicating that GcMAF rebuilds the immune system, and the immune system then eradicates early stage cancer and other diseases.
How does GcMAF work?
In a healthy person your GcMAF acts as the "commanding officer" of your immune system and also instructs macrophages in your bloodstream to scour our bodies and kill malignancies. But malignant cells like cancer send out an enzyme called Nagalase that neutralises your GcMAF; so the macrophages never get the message to go into action – in this way disease suppresses the immune system, and cancer cells grow unchecked.
To reverse this, we extract and purify GcMAF, and it is one dose a week for typically 24 weeks for many diseases and early cancers, a year for later stage cancers. Our GcMAF has had over 200 independent laboratory tests.
One week's GcMAF looks like a small raindrop. Its perfectly sterile, and a most ethical course for doctors.
We are a main supplier for research universities, together with more than 80 cancer clinics and doctors.
In its role of immune system regulator, research shows GcMAF can reverse diseases that attack the immune system like chronic inflamation, bacterial and viral infections, Autism, Chronic Herpes, Chronic Acne, CFS, XMRV, Lyme disease, AIDS, HIV, Fibromyalgia (all of which we've begun to have success with ourselves), osteoporosis, Hodgkin’s, Lupus, MS, Parkinson’s, and various types of Immune dysfunction.
Small pre-clinical trials to build the case are again taking place.
Our GcMAF destroying human cancer cells for 72 hours. At 100ng/ml, panel D, cells show an irregular shape and size. They are significantly smaller as if processes of shrinkage had occurred. Cells appear inhomogeneous and both cytoplasm and nucleus appear irregular as if fragmented. Numerous cellular debris can be observed as well as apoptotic bodies. Clusters are much fewer in number and their borders appear less defined.
Clinics, doctors and those diagnosed with any of these illnesses, and who have done their own research on it, are invited to respond. We ask for a copy of diagnostic information and update reports from a physician during and after treatments, to help build the case that GcMAF is effective for various illnesses, which will help to make it available to the public. Participants are free to stop at any time, and we can recommend a Doctor if required.
What have we learned?
The many scientists who have published papers on trials of GcMAF selected those in the early stages of cancer and HIV, and reported nearly 100 percent success, with no recurrence after many years. They did not attempt trials on people with large tumours.
Our trials are quite different: most people are over 50, some over 80, with advanced or terminal cancers, with significant tumour mass.
From an initial 20% responders we appear to have had increasingly better results in 2011 over 2010 and as research advances, the percentage successes, which are very dependent on the stage of the disease, are improving. GcMAF needs good nutrition to feed the immune system while it is being rebuilt, and normal levels of vitamin D to function strongly. But even in low responders, GcMAF usually appears to stop the advance of cancer.
We have probably proved GcMAF can work for people up to age 90, with terminal stage 4 cancer, and can destroy large tumour mass. See "Patients on GcMAF" on the left.
If you have your blood taken for monocyte counts, relevant markers and vitamin D levels, and again for a nagalase test at the beginning, you should see on your next test after three weeks that your immune system is back to full strength, and after 8 weeks significantly falling nagalase will indicate the disease is losing its grip. Finally when nagalase gets below 0.65 it loses the ability to prevent your body producing your own GcMAF, which can then take over from ours.
Autism children improve at five weeks with substantial improvements at 8 weeks. See "Participants experiences" on the left.
HIV participants who also take 9000IU of vitamin D daily can see nagalese drop to normal after 16 weeks.
But the beauty of using your own immune system to attack cancer is that it remembers how to defeat it for the rest of your life: it doesn't come back. And unlike chemotherapy, the side effects are trivial.
We have GcMAF available for preclinical trials. See "Buy GcMAF here," top left. If you have questions, click "Contact" at the top to send us an email, or call our contact person David Noakes +44 7781 411 737 10.30am to 10pm UTC/GMT.
